Presence of trisomy 19 in chronic myeloid leukemia (CML) normally considered as secondary abnormality but trisomy 19 rarely occur as sole abnormality. In the present study a total of 2312 Ph positive CML were screened from year2004 to 2014 and we found 2 cases of trisomy 19 as sole karyotype abnormalities. Both karyotype showed 47,XY,t(9;22)(q34;q11.2),+19,complements. It is not known that which gene(s) present on chromosome 19 plays important role in development of this condition.
| Published in | International Journal of Genetics and Genomics (Volume 2, Issue 4) |
| DOI | 10.11648/j.ijgg.20140204.15 |
| Page(s) | 77-79 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2014. Published by Science Publishing Group |
Trisomy 19, Sole Chromosome Abnormality, CML
| [1] | R. La Sturza, N. Testoni, M. Lafage-Pochitaloff, D.Ruggeri, E. Ottaviani, G. Perla et al., “Complex variant Philadelphia translocation involving the Short arm of chromosome 6 in CML.” Hematologica, Vol. 87, pp. 143-47 2002. |
| [2] | T.G.Lugo, A.M. Pendergast, A. J. Muller, O.N. Witte, “Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, Vol. 247, pp. 1079-82, 1990. |
| [3] | I.L.Soon, H.S.Cho, C.H.Lee, K. D. Kim, J. K.Ha, M.K. Kim, K.H. Lee, M.S.Hyun, “Two cases of Trisomy19 as a sole chromosomal abnormality in myeloid disorders”. Kor. J. Lab. Med, Vol. 28, pp. 174 – 178, 2008. |
| [4] | B. Johansson, T. Fioretos, F. Mitelman, “cytogenetic and molecular genetic evolution of chronic myeloid leukemia” Acta Hematol, Vol. 107(2), pp.76-94, 2002. |
| [5] | J. L. Diez-Martin, G.W. Dewald, R. V. Pierre, “Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia” Am. J. Hematol, Vol. 27, pp. 194-203, 1988. |
| [6] | International System for Human Cytogenetics Nomenclature (ISCN), S. Karger Pub. Inc. 2009, 2013. |
| [7] | S. Luatti, F.castagnetti, G.Marzocchi, C. Bladdazi, G. Gugliotta, I. Lacobucci et al., “Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA working party on CML analysis”, Blood, Vol. 120(4), pp. 716-67, 2012. |
| [8] | M. Daskalkis, N. Mauritzson, B. Johansson, K. Bouabdallah, F. Onida, R. Kunzamann, H. Muller-Berndroff, A. Schmidt-Graff, M. Lubbert, “Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia”. Leukemia Res. Vol. 30, pp. 1043-47, 2006. |
| [9] | R.W. Yen, P.M. Vertino, B.D. Nelkin, J.J. Yu, W. El-Deiry, A. Cumarswamy, “Isolation and characterization of c-DNA encoding human DNA methyl-transferase”, Nucleic acid Res. Vol. 20(9), pp. 2289-91, 1992. |
APA Style
Salil N. Vaniawala, Pankaj K. Gadhia. (2014). Trisomy 19 as the Sole Chromosomal Abnormality in CML. International Journal of Genetics and Genomics, 2(4), 77-79. https://doi.org/10.11648/j.ijgg.20140204.15
ACS Style
Salil N. Vaniawala; Pankaj K. Gadhia. Trisomy 19 as the Sole Chromosomal Abnormality in CML. Int. J. Genet. Genomics 2014, 2(4), 77-79. doi: 10.11648/j.ijgg.20140204.15
AMA Style
Salil N. Vaniawala, Pankaj K. Gadhia. Trisomy 19 as the Sole Chromosomal Abnormality in CML. Int J Genet Genomics. 2014;2(4):77-79. doi: 10.11648/j.ijgg.20140204.15
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijgg.20140204.15,
author = {Salil N. Vaniawala and Pankaj K. Gadhia},
title = {Trisomy 19 as the Sole Chromosomal Abnormality in CML},
journal = {International Journal of Genetics and Genomics},
volume = {2},
number = {4},
pages = {77-79},
doi = {10.11648/j.ijgg.20140204.15},
url = {https://doi.org/10.11648/j.ijgg.20140204.15},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijgg.20140204.15},
abstract = {Presence of trisomy 19 in chronic myeloid leukemia (CML) normally considered as secondary abnormality but trisomy 19 rarely occur as sole abnormality. In the present study a total of 2312 Ph positive CML were screened from year2004 to 2014 and we found 2 cases of trisomy 19 as sole karyotype abnormalities. Both karyotype showed 47,XY,t(9;22)(q34;q11.2),+19,complements. It is not known that which gene(s) present on chromosome 19 plays important role in development of this condition.},
year = {2014}
}
TY - JOUR T1 - Trisomy 19 as the Sole Chromosomal Abnormality in CML AU - Salil N. Vaniawala AU - Pankaj K. Gadhia Y1 - 2014/08/30 PY - 2014 N1 - https://doi.org/10.11648/j.ijgg.20140204.15 DO - 10.11648/j.ijgg.20140204.15 T2 - International Journal of Genetics and Genomics JF - International Journal of Genetics and Genomics JO - International Journal of Genetics and Genomics SP - 77 EP - 79 PB - Science Publishing Group SN - 2376-7359 UR - https://doi.org/10.11648/j.ijgg.20140204.15 AB - Presence of trisomy 19 in chronic myeloid leukemia (CML) normally considered as secondary abnormality but trisomy 19 rarely occur as sole abnormality. In the present study a total of 2312 Ph positive CML were screened from year2004 to 2014 and we found 2 cases of trisomy 19 as sole karyotype abnormalities. Both karyotype showed 47,XY,t(9;22)(q34;q11.2),+19,complements. It is not known that which gene(s) present on chromosome 19 plays important role in development of this condition. VL - 2 IS - 4 ER -
Information
Email: